Provectus Pharmaceuticals Inc. Release: Research on Mechanism of Action of Rose Bengal Presented at 8th World Congress of Melanoma
8/6/2013 7:35:50 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Provectus Pharmaceuticals, Inc. (OTCQB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced that research exploring the mechanism of action of Rose Bengal was presented at the 8th World Congress of Melanoma, which took place July 17 – July 20, 2013 in Hamburg, Germany.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by